Detection of HLA-C*08:178, a novel HLA-C*08 variant, in a Taiwanese hematopoietic stem cell donor

HLA : Immune Response Genetics
K L Yang, Py-Yu Lin

Abstract

Nucleotide replacement at residue 12 of HLA-C*08:22 results in a novel allele, HLA-C*08:178.

References

Apr 2, 2010·Tissue Antigens·S G E MarshJ Trowsdale
Nov 22, 2014·Nucleic Acids Research·James RobinsonSteven G E Marsh

❮ Previous
Next ❯

Citations

Jul 23, 2019·HLA : Immune Response Genetics·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System
Nov 21, 2019·HLA : Immune Response Genetics·Steven G E Marsh, UNKNOWN WHO Nomenclature Committee for Factors of the HLA System
Nov 7, 2019·International Journal of Immunogenetics·Steven G E Marsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.